Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.
Company Profile
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:
In Vitro And In Vivo Diagnostic Substances (2835)
Contact Information
Investor Relations
Rich Cockrell
T: 404-736-3838
achv@cg.capital
Company Contact
Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500